The safer management of pediatric ECMO with TEG6s

The efficacy of TEG6s as the management of anticoagulation therapy during pediatric ECMO

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1012220032

Enrollment

Registered

2022-12-26

Start date

2022-12-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure Heart Failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children less than 10 years old, who require ECMO

Exclusion criteria

Exclusion criteria: crinical confounder including extereme low birth weigh or ECMO device failure etc

Design outcomes

Primary

Measure	Time frame
Brain or tracheal hemorrage or circuit closing of ECMO	—

Secondary

Measure	Time frame
mortality	—

Contacts

Public ContactWataru Sakai

Hokkaido Medical Center for Child Health and Rehabilitation

sakaiwataru1128@gmail.com+81-116915696

Outcome results